Case report Effect of Structured Mobility Exercises along with Multi-modal Drug Therapy in A 72-yearold Male Subject with Bullous Pemphigoid – A Case Report

Senthil  Purushothaman; S.  Swathi; N.  Shazia Neelam; Vivek  Valliappan

Senthil Purushothaman Professor, Chettinad School of Physiotherapy, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Tamil Nadu, India
S. Swathi Research Scholar, Chettinad School of Physiotherapy, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Tamil Nadu, India.
N. Shazia Neelam Research Scholar, Chettinad School of Physiotherapy, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Tamil Nadu, India.
Vivek Valliappan Assistant Professor, Department of Pharmacology, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam, Tamil Nadu, India.

Keywords: Bullous Pemphigoid, Drug Therapy, Adjuvant Therapy, Mobility Exercise, Physical Function

Abstract

Introduction: Bullous pemphigoid (BP) is an acquired autoimmune blistering disease occurring in the elderly (more than 70 years of age).
Case Report: We pre-sent a case of a 72-year-old male, a known case of hypertension and diabetes mellitus, with an abrupt onset of fluidfilled vesicles and bullae over the groin, abdomen and limbs for 3 months, associated with itching. Medications of corticosteroids and immunosuppressants along with adjuvant therapy were started to manage the skin lesions. Graded structured mobility exercises were also added in a gradual and progressive manner for 12 weeks. The physical mobility of the subject was assessed along with multi-modal
drug therapy after 12 weeks of intervention. Values at baseline and post-12 weeks of intervention assessed using the Patient Specific Functional Scale showed improvement in physical activity level and skin lesion.
Conclusion: Bullous pemphigoid can be monitored with drug dosage and choice of drugs in controlling the skin lesion as well as reducing the risk of disease complications. Along with the multi-modal drug therapy, the graded mobility exercise advised in this case proved to be more beneficial in his physical functional level.

How to cite this article:

Effect of Structured Mobility Exercises along with Multi-modal Drug Therapy in A 72-year-old Male Subject with Bullous Pemphigoid – A Case Report. J Commun Dis. 2023;54(4):51-53.

DOI: https://doi.org/10.24321/0019.5138.202354

References

Raveendran MN, Srinivasan SM. Postpartum bullous pemphigoid–a case report. Our Dermatol Online.

;8(2):160-163. DOI: 10.7241/ourd.20172.43 [Google Scholar]

Khalid SN, Khan ZA, Ali MH, Almas T, Khedro T, Nagarajan VR. A blistering new era for bullous pemphigoid: a

scoping review of current therapies, ongoing clinical trials, and future directions. Ann Med Surg (Lond).

;70:102799. [PubMed] [Google Scholar]

Kluger N, Pankakoski A, Panelius J. Depression and anxiety in patients with bullous pemphigoid: impact

and management challenges. Clin Cosmet Investig Dermatol. 2020 Jan 21;13:73-6. [PubMed] [Google

Scholar]

Miyamoto D, Santi CG, Aoki V, Maruta CW. Bullous pemphigoid. An Bras Dermatol. 2019;94(2):133-46.

[PubMed] [Google Scholar]

Timoteo RP, Sales-Campos H, Silva MV, da Silva DA, Catarino JD, de Sousa MA, Júnior VR, E Silva LE, Bittencourt AC, Carneiro ÉM, Oliveira CJ. Pemphigus foliaceus patients (Fogo Selvagem) treated with kinesiotherapy presented lower levels of proinflammatory cytokines. J Exerc Rehabil. 2019 Jun;15(3):460. [PubMed] [Google Scholar]

Hefford C, Abbott JH, Arnold R, Baxter GD. The patient-specific functional scale: validity, reliability,

and responsiveness in patients with upper extremity musculoskeletal problems. J Orthop Sports Phys Ther.

Feb;42(2):56-65. [PubMed] [Google Scholar]

Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New onset of autoimmune diseases following

COVID-19 diagnosis. Cells. 2021 Dec 20;10(12):3592. [PubMed] [Google Scholar]

Perez-Lopez I, Moyano-Bueno D, Ruiz-Villaverde R. Bullous pemphigoid and COVID-19 vaccine. Med Clin

(Engl Ed.). 2021;157(10):e333. [PubMed] [Google Scholar]